![Jonathan Rigby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Rigby
Chief Executive Officer at
SERNOVA BIOTHERAPEUTICS INC
Net worth: 69 264 $ as of 2026-05-30
Profile
Mr. Jonathan M.
Rigby is a Chief Executive Officer at Sernova Biotherapeutics, Inc., a Chairman & Chief Business Officer at BioPlus Acquisition Corp.
and a Chairman at Association of Needle-Free Injection Manufacturers.
He is on the Board of Directors at Oncolytics Biotech, Inc., Aurimi Therapeutics, Inc., Exciting Instruments Ltd., ReAlta Life Sciences, Inc. and Thermalin, Inc. Mr. Rigby was previously employed as a President, Group CEO & Director by Revolo Biotherapeutics Ltd., a Chairman by CollPlant Biotechnologies Ltd., an Independent Non-Executive Director by Xeris Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by SteadyMed Ltd., a President, Chief Executive Officer & Director by SteadyMed Therapeutics, Inc., a Vice President-Business Development by Zogenix, Inc., a Vice President-Business Development by Aradigm Corp., a Head-Business Development & Sales by Profile Therapeutics Plc, and a Principal by Merck & Co., Inc. He received his undergraduate degree from The University of Sheffield and an MBA from the University of Portsmouth.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-31 | 42,728 ( 0.04% ) | 44 437 $ | 2026-05-30 | |
| 2026-04-13 | 229,877 ( 0.07% ) | 24 827 $ | 2026-05-30 |
Jonathan Rigby active positions
| Companies | Position | Start |
|---|---|---|
| BIOPLUS ACQUISITION CORP. | Chairman | 2021-06-30 |
| ONCOLYTICS BIOTECH INC. | Director/Board Member | 2022-08-29 |
| SERNOVA BIOTHERAPEUTICS INC | Chief Executive Officer | 2024-08-11 |
Thermalin, Inc.
 Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Develops insulin treatments for patients with diabetes | Director/Board Member | - |
ImmunoMolecular Therapeutics, Inc.
 ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Director/Board Member | 2021-01-26 |
Association of Needle-Free Injection Manufacturers | Chairman | 2010-09-06 |
ReAlta Life Sciences, Inc.
 ReAlta Life Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel class of drugs with dual-targeting therapeutic capabilities | Director/Board Member | - |
Former positions of Jonathan Rigby
| Companies | Position | End |
|---|---|---|
Revolo Biotherapeutics Ltd.
 Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops immunologic and inflammatory medications | Chief Executive Officer | 2024-02-21 |
| STEADYMED LTD | Chief Executive Officer | 2019-12-31 |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Jonathan Rigby
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
50
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for the treatment and prevention of respiratory diseases | Health Technology |
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
Sernova Biotherapeutics, Inc.
 Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines | Health Technology |
Respironics Ltd.
 Respironics Ltd. Financial ConglomeratesFinance Develops and manufactures medical and healthcare products | Finance |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Portsmouth
 University of Portsmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association of Needle-Free Injection Manufacturers | |
SteadyMed Therapeutics, Inc.
 SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops drug delivery therapeutics devices | Health Services |
Thermalin, Inc.
Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Develops insulin treatments for patients with diabetes | Health Technology |
CollPlant Biotechnologies Ltd.
 CollPlant Biotechnologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes medical devices | Health Technology |
SteadyMed Ltd.
 SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, and manufacture of pharmaceutical products | Health Technology |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Health Technology |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops immunologic and inflammatory medications | Health Technology |
ReAlta Life Sciences, Inc.
ReAlta Life Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel class of drugs with dual-targeting therapeutic capabilities | Health Technology |
BioPlus Acquisition Corp.
 BioPlus Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Stock Market
- Insiders
- Jonathan Rigby
